Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Kenvue

Tylenol maker sells to Kimberly Clark for $48B weeks after Trump and RFK Jr targeted drug

The deal announced Monday is among the largest corporate takeovers of the year

The Independent UK

Kimberly-Clark Stock Plunges Over 16%, Kenvue Surges 20% In Monday Pre-Market: What's Going On?

Shares of Kimberly-Clark Corporation (NASDAQ:KMB) plunged 16.15% during the pre-market trading session on Monday, after it announced the acquisition of Kenvue Inc. (NYSE:KVUE) on Monday. Meanwhile Kenvue stock surged 20.04%.

Benzinga

Do Wall Street Analysts Like Kenvue Stock?

Despite Kenvue’s underperformance relative to the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Hold Ratings, High Rewards? 3 Stocks That Could Defy Expectations

Patience and a tolerance for risk may be necessary, but these Hold stocks could eventually see big gains, according to analysts.

MarketBeat

Texas Sues Johnson & Johnson for 'Hiding' Tylenol Autism Risks — Billions at Stake in Landmark Case

Texas sues Tylenol's makers over autism risks, echoing Trump-era legal battles over health misinformation with potential billions at stake.

International Business Times UK

Texas sues Tylenol makers alleging deceptive marketing to pregnant people

Lawsuit comes after Trump’s baseless claims that acetaminophen can cause autism and ADHD in children

The Guardian - US

Ken Paxton Alleges Johnson & Johnson Misled Mothers On Tylenol Safety

Texas Attorney General Ken Paxton has filed a lawsuit against Johnson Johnson (NYSE:JNJ) and Kenvue Inc (NYSE:KVUE), accusing the companies of misleading pregnant women about the safety of Tylenol despite evidence suggesting its active ingredient, acetaminophen, may increase the risk of autism and attention disorders in children.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Texas Attorney General Targets Tylenol Makers in Controversial Autism Lawsuit

Texas Attorney General Ken Paxton sues Johnson & Johnson and Kenvue, alleging they hid risks linking prenatal Tylenol use to autism and ADHD in children.

International Business Times UK

Texas sues Tylenol makers over RFK Jr autism claims saying they failed to state ‘risk of taking drug while pregnant’

State Attorney General Ken Paxton parroted claims by the Health Secretary which have been strongly refuted by medical professionals

The Independent UK

Texas attorney general sues Tylenol company over autism claims

This lawsuit comes a month after U.S. Health Secretary Robert F. Kennedy, Jr. updated guidance discouraging pregnant women from taking acetaminophen, citing it as a possible cause of autism.

The Texas Tribune

3 Dividend Aristocrats So Cheap, Analysts Call Them Buys

These Dividend Aristocrats are trading below the sector average, offer strong yields, and stability.

Barchart

Unusually Active: 4 Options to Watch Next Month for Potential Future Gains

Overall options volume was about average on Thursday, with calls accounting for 60% of the action. Of the 1,291 unusually active options on the day, here are four to watch in the next month.

Barchart

Neutrogena makeup remover face wipes recalled in these states over bacteria concerns

More than 1,000 cases of the Neutrogena Makeup Remover Ultra-Soft Cleansing Towelettes have been recalled

The Independent UK

Kenvue's Quarterly Earnings Preview: What You Need to Know

Kenvue is expected to announce its third-quarter results by early November, and analysts expect a notable decline in earnings.

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Tylenol-Maker Kenvue’s Stock Is Down 30% in 2025. Its Fate May Be in the FDA’s Hands.

The former consumer health unit of Johnson & Johnson remains mired in troubles surrounding Tylenol.

Barchart

This Billionaire Investor Is ‘Thrilled’ to Own Kenvue Stock Despite Tylenol Turbulence. Should You Buy KVUE Here?

Kenvue stock is down 28% in 2025 amid controversy surrounding its Tylenol brand, which is linked to autism when used during pregnancy.

International Business Times UK

64-Year-Old Blames Johnson & Johnson for Her Ovarian Cancer — Joins 3,000 Suing the Pharma Giant

UK's first talc cancer group claim accuses Johnson & Johnson and Kenvue of failing to warn about asbestos risk — £1 billion suit backed by 3,000 claimants.

The Guardian - UK

Thousands in UK take legal action against Johnson & Johnson over alleged talc cancer link

High court claim says company knowingly sold product containing asbestos and ‘concealed’ risk to public

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

‘When I was a child, everyone used it’: woman blames Johnson & Johnson talc for her cancer

Sue Rizzello is among thousands in UK suing the firm, which denies selling baby powder containing asbestos

The Independent UK

Thousands sue Johnson & Johnson in UK over baby powder cancer claims

The pharmaceutical company has been accused of ‘concealing’ the risk to the public for decades

Benzinga

Options Corner: Despite Political Woes, Kenvue Can Still Make Tylenol Great Again

Amid a contentious political environment, consumer pharmaceutical firm Kenvue Inc (NYSE:KVUE) finds itself under a harsh spotlight. Specifically, its popular drug Tylenol has attracted the ire of the White House. Late last month, President Donald Trump stated on Truth Social that pregnant women shouldn't use Tylenol unless absolutely necessary. With…

Fortune

'This team is guided by science': Kenvue chief hits back at Trump and RFK Jr.'s Tylenol autism claims in memo to 20,000 employees

Promotion of unproven claims from President Trump and RFK Jr. linking acetaminophen (Tylenol) to autism have significantly impacted Kenvue’s business.

Benzinga

White House Highlights A Controversial 2017 Tylenol Tweet On Its Usage During Pregnancy: 'We Actually Don't Recommend…'

A 2017 post by Tylenol on X (formerly Twitter) highlighted by White House has fueled a buzz around President Donald Trump‘s claim that the drug is linked with autism in kids.

The Independent UK

RFK Jr. wanted to blame Tylenol for autism after meeting with drugmaker CEO

Trump was eager to single out drug manufacturer despite no new evidence to support administration’s unproven claims

Barchart

As Trump Takes Aim at Tylenol, Should You Buy, Sell, or Hold Parent Company Kenvue Stock’s Here?

Kenvue stock is trailing the broader markets by a wide margin in 2025 due to regulatory concerns over its flagship Tylenol product.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Food and Drug Administration

196 stories

USDC

151 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.